These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 27646437)

  • 41. Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis.
    St John JA; Ekberg JA; Dando SJ; Meedeniya AC; Horton RE; Batzloff M; Owen SJ; Holt S; Peak IR; Ulett GC; Mackay-Sim A; Beacham IR
    mBio; 2014 Apr; 5(2):e00025. PubMed ID: 24736221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.
    Chirakul S; Bartpho T; Wongsurawat T; Taweechaisupapong S; Karoonutaisiri N; Talaat AM; Wongratanacheewin S; Ernst RK; Sermswan RW
    PLoS One; 2014; 9(8):e104313. PubMed ID: 25111708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei.
    Chin CY; Monack DM; Nathan S
    Immunology; 2012 Apr; 135(4):312-32. PubMed ID: 22136109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of Luminescence- and Fluorescence-Tagged
    Shin YW; Park DB; Choi MM; Chun JH; Seong BL; Rhie GE
    J Microbiol Biotechnol; 2018 Mar; 28(3):498-502. PubMed ID: 29212292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapsed Melioidosis Model in C57BL/6 Mice.
    Panomket P; Wongsana P; Wanram S; Wongratanacheewin S; Bartpho T
    J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S1-6. PubMed ID: 26817231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
    Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
    Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 48. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
    Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
    Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.
    Ulett GC; Ketheesan N; Clair TW; McElnea CL; Barnes JL; Hirst RG
    Infect Immun; 2002 Jul; 70(7):3953-8. PubMed ID: 12065542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
    Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.
    Breitbach K; Klocke S; Tschernig T; van Rooijen N; Baumann U; Steinmetz I
    Infect Immun; 2006 Nov; 74(11):6300-9. PubMed ID: 17000727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmacytoid dendritic cell bactericidal activity against Burkholderia pseudomallei.
    Williams NL; Morris JL; Rush CM; Ketheesan N
    Microbes Infect; 2015 Apr; 17(4):311-6. PubMed ID: 25532693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.
    Challacombe JF; Stubben CJ; Klimko CP; Welkos SL; Kern SJ; Bozue JA; Worsham PL; Cote CK; Wolfe DN
    PLoS One; 2014; 9(12):e115951. PubMed ID: 25536074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial loads and antibody responses in BALB/c mice infected with low and high doses of Burkholderia pseudomallei.
    Srisurat N; Sermswan RW; Tatawasart U; Wongratanacheewin S
    Am J Trop Med Hyg; 2010 Jun; 82(6):1102-5. PubMed ID: 20519607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.
    Pinweha P; Pumirat P; Cuccui J; Jitprasutwit N; Muangsombut V; Srinon V; Boonyuen U; Thiennimitr P; Vattanaviboon P; Cia F; Willcocks S; Bancroft GJ; Wren BW; Korbsrisate S
    PLoS One; 2018; 13(5):e0196202. PubMed ID: 29771915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.
    Trevino SR; Klimko CP; Reed MC; Aponte-Cuadrado MJ; Hunter M; Shoe JL; Meyer JR; Dankmeyer JL; Biryukov SS; Quirk AV; Fritts KA; Kern SJ; Fetterer DP; Kohler LJ; Toothman RG; Bozue JA; Schellhase CW; Kreiselmeier N; Daye SP; Welkos SL; Soffler C; Worsham PL; Waag DM; Amemiya K; Cote CK
    PLoS One; 2018; 13(11):e0208277. PubMed ID: 30500862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
    Wongratanacheewin S; Kespichayawattana W; Intachote P; Pichyangkul S; Sermswan RW; Krieg AM; Sirisinha S
    Infect Immun; 2004 Aug; 72(8):4494-502. PubMed ID: 15271908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caspase-4 Mediates Restriction of Burkholderia pseudomallei in Human Alveolar Epithelial Cells.
    Srisaowakarn C; Pudla M; Ponpuak M; Utaisincharoen P
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31818963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
    Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
    J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.